MiMedx Group, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
MiMedx Group, Inc. (MDXG) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.32 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-02-25
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was $0.11, a 120.00% increase year-over-year.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was $0.06, a 50.00% decline year-over-year.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was $0.05, a 16.67% decline year-over-year.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was $0.05, a 16.67% decline year-over-year.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for fiscal 2025 was $0.32, a 14.29% increase from fiscal 2024.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for fiscal 2024 was $0.28, a 34.88% decline from fiscal 2023.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for fiscal 2023 was $0.43.
- MiMedx Group, Inc. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$0.24.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.32 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $0.11 10-Q · filed 2025-10-29 | $0.22 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $0.06 10-Q · filed 2025-07-30 | $0.11 10-Q · filed 2025-07-30 | ||
| 2025-03-31 | $0.05 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | $0.28 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $0.05 10-Q · filed 2025-10-29 | $0.23 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | $0.12 10-Q · filed 2025-07-30 | $0.18 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $0.06 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $0.43 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $0.06 10-Q · filed 2024-10-30 | $0.09 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $0.06 10-Q · filed 2024-07-31 | $0.04 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | -$0.03 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | -$0.24 10-K · filed 2025-02-26 | |||
| 2021-12-31 | -$0.17 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |